Literature DB >> 4625628

Cross-resistance of Pseudomonas to gentamicin and tobramycin.

J L Brusch, M Barza, M G Bergeron, L Weinstein.   

Abstract

Clinical isolates of gentamicin-resistant organisms were found to be resistant to tobramycin, a new aminoglycoside antibiotic.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4625628      PMCID： PMC444207          DOI： 10.1128/AAC.1.3.280

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  3 in total

1.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

2.  Preliminary studies with nebramycin factor 6.

Authors:  H R Black; R S Griffith
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

3.  Nebramycin, a new broad-spectrum antibiotic complex. IV. In vitro and in vivo laboratory evaluation.

Authors:  W E Wick; J S Welles
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967
  3 in total
  13 in total

1.  Comparative in vivo activities of cefsulodin, sulbenicillin, and gentamicin against Pseudomonas aeruginosa.

Authors:  M Kondo; K Tsuchiya
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

2.  Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.

Authors:  B H Minshew; H M Pollock; F D Schoenknecht; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

3.  Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment.

Authors:  S R Westenfelder; G Welling; P O Madsen
Journal:  Infection       Date:  1974       Impact factor: 3.553

4.  Is there complete cross-resistance of gram-negative bacilli to gentamicin and tobramycin?

Authors:  C C Crowe; E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1972-11       Impact factor: 5.191

5.  Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.

Authors:  M I Marks; S Hammerberg; G Greenstone; B Silver
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

6.  [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].

Authors:  H H Schassan
Journal:  Infection       Date:  1976       Impact factor: 3.553

7.  Transferrable resistance to tobramycin in Klebsiella pneumoniae and Enterobacter cloacae associated with enzymatic acetylation of tobramycin.

Authors:  B H Minshew; R K Holmes; J P Sanford; C R Baxter
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

8.  Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.

Authors:  R M Kluge; H C Standiford; B Tatem; V M Young; W H Greene; S C Schimpff; F M Calia; R B Hornick
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

9.  Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.

Authors:  K E Price; T A Pursiano; M D DeFuria
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

10.  Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials.

Authors:  W R Lockwood; L A Lawson
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.